
Pro-Dex PDEX
$ 66.5
5.88%
Country |
|
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
3.23 B |
Market Cap[1] |
$ 215 B |
EBITDA (LTM) |
$ 14.4 M |
P/E (LTM) |
18.3525 |
P/S (LTM) |
3123.964705 |
EPS (LTM) |
4.0 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Alcon
ALC
|
$ 67.69 | 2.51 % | $ 33.4 B | NYSE | ||
|
AngioDynamics
ANGO
|
$ 15.33 | 0.39 % | $ 637 M | Nasdaq Global Select Market | ||
|
AtriCure
ATRC
|
$ 55.77 | 2.26 % | $ 2.66 B | Nasdaq Global Market,SPB | ||
|
Baxter International
BAX
|
$ 23.77 | 0.02 % | $ 12.2 B | NYSE,SPB | ||
|
Becton, Dickinson and Company
BDX
|
$ 182.19 | 2.44 % | $ 52.4 B | NYSE,SPB | ||
|
BioLife Solutions
BLFS
|
$ 35.21 | 0.75 % | $ 1.68 B | Nasdaq Global Select Market | ||
|
The Cooper Companies
COO
|
$ 54.19 | 0.52 % | $ 10.8 B | NYSE,SPB | ||
|
electroCore
ECOR
|
$ 9.7 | 0.78 % | $ 82.3 K | Nasdaq Global Select Market | ||
|
Glaukos Corporation
GKOS
|
$ 170.53 | 1.96 % | $ 9.75 B | NYSE,SPB | ||
|
Haemonetics Corporation
HAE
|
$ 106.92 | 4.12 % | $ 5.04 B | NYSE,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 8.04 | 0.06 % | $ 357 M | Nasdaq Global Market | ||
|
ICU Medical
ICUI
|
$ 157.16 | 0.43 % | $ 3.87 B | Nasdaq Global Select Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 12.24 | 0.74 % | $ 253 M | NYSE American | ||
|
iRhythm Technologies
IRTC
|
$ 114.34 | 2.61 % | $ 3.66 B | Nasdaq Global Select Market,SPB | ||
|
Intuitive Surgical
ISRG
|
$ 377.15 | 2.17 % | $ 135 B | Nasdaq Global Select Market,SPB | ||
|
Repro Med Systems
KRMD
|
$ 3.13 | 0.32 % | $ 145 M | Nasdaq Capital Market | ||
|
LeMaitre Vascular
LMAT
|
$ 80.52 | 0.07 % | $ 1.82 B | Nasdaq Global Market,SPB | ||
|
Microbot Medical
MBOT
|
$ 1.45 | 0.08 % | $ 66.4 M | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.42 | 2.28 % | $ 34.5 M | NYSE American | ||
|
Merit Medical Systems
MMSI
|
$ 86.96 | 0.69 % | $ 5.14 B | Nasdaq Global Select Market,SPB | ||
|
Nephros
NEPH
|
$ 4.39 | 0.22 % | $ 46.6 M | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 25.88 | 1.29 % | $ 4.35 B | NYSE | ||
|
Pulse Biosciences
PLSE
|
$ 54.82 | 3.21 % | $ 3.69 B | Nasdaq Global Select Market | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 166.82 | 0.99 % | $ 9.38 M | Nasdaq Global Select Market,SPB | ||
|
ResMed
RMD
|
$ 223.19 | 2.25 % | $ 32.5 B | NYSE,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.69 | 2.11 % | $ 20.7 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 23.01 | 1.54 % | $ 1.14 B | Nasdaq Global Market,SPB | ||
|
STERIS plc
STE
|
$ 213.5 | 1.3 % | $ 21 B | NYSE,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 130.93 | 0.34 % | $ 5.84 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 71.05 | 1.92 % | $ 230 M | Nasdaq Global Select Market | ||
|
DENTSPLY SIRONA
XRAY
|
$ 10.41 | 0.62 % | $ 2.08 B | Nasdaq Global Select Market,SPB | ||
|
OraSure Technologies
OSUR
|
$ 3.34 | 2.77 % | $ 245 M | Nasdaq Global Select Market,SPB | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Stereotaxis
STXS
|
$ 1.34 | 3.49 % | $ 122 M | NYSE American | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
West Pharmaceutical Services
WST
|
$ 355.29 | 2.62 % | $ 25.7 B | NYSE,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Masimo Corporation
MASI
|
- | - | $ 9.59 B | Nasdaq Global Select Market,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.